| scholarly article | Q13442814 |
| P2093 | author name string | J Xu | |
| Y He | |||
| M R Farlow | |||
| R Lane | |||
| S Tekin | |||
| H C Charles | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cognitive dysfunction | Q57859955 |
| mild cognitive impairment | Q1472703 | ||
| P304 | page(s) | 1898-901 | |
| P577 | publication date | 2004-11-23 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Impact of APOE in mild cognitive impairment | |
| P478 | volume | 63 |
| Q37635614 | A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease |
| Q58615680 | A structural equation model for imaging genetics using spatial transcriptomics |
| Q97529784 | APOE - a genetic marker of comorbidity in subjects with morbid obesity |
| Q33822745 | APOE Affects the Volume and Shape of the Amygdala and the Hippocampus in Mild Cognitive Impairment and Alzheimer's Disease: Age Matters |
| Q92702373 | APOE Promoter Polymorphism-219T/G is an Effect Modifier of the Influence of APOE ε4 on Alzheimer's Disease Risk in a Multiracial Sample |
| Q33895819 | APOE moderates the association between lifestyle activities and cognitive performance: evidence of genetic plasticity in aging. |
| Q36345189 | APOE status and its association to learning and memory performance in middle aged and older Norwegians seeking assessment for memory deficits |
| Q37623222 | APOE ε4 worsens hippocampal CA1 apical neuropil atrophy and episodic memory |
| Q33423191 | APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging |
| Q90644043 | APOE4 moderates effects of cortical iron on synchronized default mode network activity in cognitively healthy old-aged adults |
| Q92691831 | APOEɛ4 Gene Dose and Sex Effects on Alzheimer's Disease MRI Biomarkers in Older Adults with Mild Cognitive Impairment |
| Q38066233 | Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade. |
| Q33924413 | Amblyomma sculptum tick saliva: α-Gal identification, antibody response and possible association with red meat allergy in Brazil |
| Q40481227 | ApoE ε4 Is Associated With Cognition, Brain Integrity, and Atrophy in HIV Over Age 60. |
| Q50669564 | Apolipoprotein E alleles in Cuban patients with mild cognitive impairment. |
| Q28282855 | Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy |
| Q37262011 | Association between APOE epsilon 2/epsilon 3/epsilon 4 polymorphism and disability severity in a national long-term care survey sample |
| Q44239855 | Associations of APOE ε4 With Health and Financial Literacy Among Community-Based Older Adults Without Dementia. |
| Q28264556 | Beta-amyloid deposition and the aging brain |
| Q41449688 | Clinical Dementia Rating Orientation Score as an Excellent Predictor of the Progression to Alzheimer's Disease in Mild Cognitive Impairment |
| Q33737786 | Clinical genetics of Alzheimer's disease |
| Q36142255 | Clinical trials in mild cognitive impairment: lessons for the future |
| Q33701135 | Conversion Discriminative Analysis on Mild Cognitive Impairment Using Multiple Cortical Features from MR Images |
| Q33926616 | Coronary heart disease is associated with non-amnestic mild cognitive impairment |
| Q57086548 | Differences in grey and white matter atrophy in amnestic mild cognitive impairment and mild Alzheimer’s disease |
| Q48147971 | Different Hippocampus Functional Connectivity Patterns in Healthy Young Adults with Mutations of APP/Presenilin-1/2 and APOEε4. |
| Q90263999 | Differential Associations Between Volumes of Atrophic Cortical Brain Regions and Memory Performances in Early and Late Mild Cognitive Impairment |
| Q34583924 | Dissecting the gene dose-effects of the APOE ε4 and ε2 alleles on hippocampal volumes in aging and Alzheimer's disease |
| Q37510386 | Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease |
| Q36841824 | Effect of the APOE Polymorphism and Age Trajectories of Physiological Variables on Mortality: Application of Genetic Stochastic Process Model of Aging |
| Q48930078 | Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease |
| Q90464711 | Effects of low- and high-intensity physical exercise on physical and cognitive function in older persons with dementia: a randomized controlled trial |
| Q35920548 | Epidemiology of Alzheimer disease |
| Q34135724 | Estimating and disclosing the risk of developing Alzheimer‘s disease: challenges, controversies and future directions |
| Q92201009 | Evaluation of hippocampal volume and serum brain-derived neurotrophic factor as potential diagnostic markers of conversion from amnestic mild cognitive impairment to Alzheimer disease: A STROBE-compliant article |
| Q58693792 | Exploring Genetic Associations of Alzheimer’s Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes |
| Q97684707 | Factors influencing recovery from mild traumatic brain injury |
| Q46338549 | Genetic influences on cognition in progressive supranuclear palsy. |
| Q37349611 | Health-protective and adverse effects of the apolipoprotein E epsilon2 allele in older men |
| Q33495745 | Hippocampal volumes are important predictors for memory function in elderly women |
| Q38712198 | Homocysteine and Mild Cognitive Impairment: Are These the Tools for Early Intervention in the Dementia Spectrum? |
| Q39657626 | Human ApoE ɛ2 Promotes Regulatory Mechanisms of Bioenergetic and Synaptic Function in Female Brain: A Focus on V-type H+-ATPase |
| Q51910066 | Identification of responders and reactive domains to rivastigmine in Alzheimer's disease. |
| Q38428635 | Impact of Apolipoprotein E4 Polymorphism on the Gray Matter Volume and the White Matter Integrity in Subjective Memory Impairment without White Matter Hyperintensities: Voxel-Based Morphometry and Tract-Based Spatial Statistics Study under 3-Tesla M |
| Q35224265 | Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment |
| Q44556621 | Impaired cortical oscillatory coupling in mild cognitive impairment: anatomical substrate and ApoE4 effects. |
| Q46300833 | Interaction effects of subjective memory impairment and ApoE4 genotype on episodic memory and hippocampal volume |
| Q89723155 | Interethnic differences in neuroimaging markers and cognition in Asians, a population-based study |
| Q36806657 | Is mild cognitive impairment a valid target of therapy |
| Q39233501 | Is sporadic Alzheimer's disease a developmental disorder? |
| Q29249048 | Job Strain and Cognitive Decline: A Prospective Study of the Framingham Offspring Cohort |
| Q36044934 | Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease |
| Q37402321 | Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. |
| Q30744917 | Mapping the effect of the apolipoprotein E genotype on 4-year atrophy rates in an Alzheimer disease-related brain network |
| Q46300936 | Memory in individuals with mild cognitive impairment in relation to APOE and CSF Abeta42. |
| Q39224343 | Moderating risk of Alzheimer's disease through the use of anxiolytic agents |
| Q46082316 | Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum |
| Q35080546 | Neurobiology of cognitive aging: insights from imaging genetics |
| Q39293135 | Obesity, Apolipoprotein E ε4, and Difficulties in Activities of Daily Living Among Older Adults: a 6-Year Follow-up Study |
| Q40032129 | Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials |
| Q35825830 | Presence of ApoE ε4 allele associated with thinner frontal cortex in middle age. |
| Q51852631 | Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjects. |
| Q50535439 | Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment. |
| Q38659590 | Role of Apolipoproteins and α-Synuclein in Parkinson's Disease. |
| Q34058281 | Should the ApoE genotype be a covariate for clinical trials in Alzheimer disease? |
| Q51926708 | Subjective memory complaints in Chinese subjects with mild cognitive impairment and early Alzheimer's disease. |
| Q34717480 | Synergistic associations of catechol-O-methyltransferase and brain-derived neurotrophic factor with executive function in aging are selective and modified by apolipoprotein E. |
| Q52585260 | The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review. |
| Q64121665 | The Contribution of Genetic Factors to Cognitive Impairment and Dementia: Apolipoprotein E Gene, Gene Interactions, and Polygenic Risk |
| Q90745423 | The Specific Impact of Apolipoprotein E Epsilon 2 on Cognition and Brain Function in Cognitively Normal Elders and Mild Cognitive Impairment Patients |
| Q28714850 | The apolipoprotein E (APOE) gene appears functionally monomorphic in chimpanzees (Pan troglodytes) |
| Q41946920 | The effect of ApoE e4 on blood pressure in patients with and without depression |
| Q90450363 | The effect of ApoE ε 4 on clinical and structural MRI markers in prodromal Alzheimer's disease |
| Q36029826 | The effects of prolonged stress and APOE genotype on memory and cortisol in older adults |
| Q47705256 | The influence of chronic stress on anxiety-like behavior and cognitive function in different human GFAP-ApoE transgenic adult male mice |
| Q36729508 | The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI). |
| Q38206263 | The role of apolipoprotein E in neurodegeneration and cardiovascular disease |
| Q34981216 | Trade-off in the effects of the apolipoprotein E polymorphism on the ages at onset of CVD and cancer influences human lifespan |
| Q34013606 | Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia |
Search more.